168 related articles for article (PubMed ID: 11781522)
1. CD10 is a marker for normal and neoplastic endometrial stromal cells.
Toki T; Shimizu M; Takagi Y; Ashida T; Konishi I
Int J Gynecol Pathol; 2002 Jan; 21(1):41-7. PubMed ID: 11781522
[TBL] [Abstract][Full Text] [Related]
2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
3. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
McCluggage WG; Sumathi VP; Maxwell P
Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
[TBL] [Abstract][Full Text] [Related]
4. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.
Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H
Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480
[TBL] [Abstract][Full Text] [Related]
5. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
Srodon M; Klein WM; Kurman RJ
Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
7. Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains.
Bhargava R; Shia J; Hummer AJ; Thaler HT; Tornos C; Soslow RA
Mod Pathol; 2005 Jan; 18(1):40-7. PubMed ID: 15309019
[TBL] [Abstract][Full Text] [Related]
8. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors.
Jung CK; Jung JH; Lee A; Lee YS; Choi YJ; Yoon SK; Lee KY
Mod Pathol; 2008 Jun; 21(6):756-63. PubMed ID: 18376386
[TBL] [Abstract][Full Text] [Related]
10. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
Chu PG; Arber DA; Weiss LM; Chang KL
Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
[TBL] [Abstract][Full Text] [Related]
11. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
Oliva E; Young RH; Amin MB; Clement PB
Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
[TBL] [Abstract][Full Text] [Related]
13. IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus.
Busca A; Gulavita P; Parra-Herran C; Islam S
Int J Gynecol Pathol; 2018 Jul; 37(4):372-378. PubMed ID: 28700435
[TBL] [Abstract][Full Text] [Related]
14. Use of myocardin in the classification of mesenchymal tumors of the uterus.
Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H
Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936
[TBL] [Abstract][Full Text] [Related]
15. Uterine epithelioid endometrial stromal sarcoma presenting as a "cervical polyp".
Goh SG; Chuah KL; Chew SH; Tan PH
Ann Diagn Pathol; 2005 Apr; 9(2):101-5. PubMed ID: 15806518
[TBL] [Abstract][Full Text] [Related]
16. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant].
Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M
Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994
[TBL] [Abstract][Full Text] [Related]
17. Myxoid endometrial stromal sarcoma of the uterus.
Kasashima S; Kobayashi M; Yamada M; Oda Y
Pathol Int; 2003 Sep; 53(9):637-41. PubMed ID: 14507323
[TBL] [Abstract][Full Text] [Related]
18. CD10 is helpful in detecting occult or inconspicuous endometrial stromal cells in cases of presumptive endometriosis.
Groisman GM; Meir A
Arch Pathol Lab Med; 2003 Aug; 127(8):1003-6. PubMed ID: 12873175
[TBL] [Abstract][Full Text] [Related]
19. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors.
Oliva E; Clement PB; Young RH
Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 and p16INK4 positive endometrial stromal sarcoma: a case report with new insights.
Rekhi B; Motghare P
Indian J Pathol Microbiol; 2014; 57(4):606-8. PubMed ID: 25308017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
